SEC Filings

424B5
AVEXIS, INC. filed this Form 424B5 on 06/19/2017
Entire Document
 

Table of Contents

deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us.

          An increase of $10.0 million of shares of common stock offered by us would increase the number of shares of common stock to be issued by us in the offering by 141,084 shares, would increase the as adjusted net tangible book value per share, after giving effect to this offering, by $0.24, and would decrease the dilution to investors purchasing shares in this offering by approximately $0.24 per share, assuming that the assumed public offering price remains the same, and after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us.

          A decrease of $10.0 million of shares of common stock offered by us would decrease the number of shares of common stock to be issued by us in the offering by 141,084 shares, would decrease the as adjusted net tangible book value per share, after giving effect to this offering, by $0.25, and increase the dilution to investors purchasing shares in this offering by approximately $0.25 per share, assuming that the assumed public offering price remains the same, and after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us.

          The as adjusted information discussed above is illustrative only and will be adjusted based on the actual public offering price and other terms of this offering determined at pricing.

          The information above assumes that the underwriters do not exercise their option to purchase additional shares. If the underwriters exercise in full their option to purchase $30,000,000 of additional shares of our common stock at the assumed public offering price of $70.88 per share, the last reported sale price of our common stock on The NASDAQ Global Select Market on June 16, 2017, our net tangible book value on March 31, 2017, after giving effect to this offering, would have been approximately $437.2 million, or approximately $14.11 per share, representing an immediate dilution of $56.77 per share to new investors purchasing shares of common stock in this offering.

          The number of shares of our common stock to be outstanding immediately following this offering as shown above is based on 27,743,174 shares of our common stock outstanding as of March 31, 2017 and excludes:

    2,734,141 shares of common stock issuable upon exercise of outstanding stock options as of March 31, 2017, at a weighted-average exercise price of $25.40 per share;

    106,232 shares of common stock issuable upon the settlement of outstanding restricted stock units as of March 31, 2017;

    305,775 shares of common stock issuable upon the exercise of outstanding warrants as of March 31, 2017, at a weighted-average exercise price of $2.57 per share; and

    up to a maximum of 2,607,080 shares of common stock reserved for future issuance under our 2016 Equity Incentive Plan, or the 2016 Plan, as of March 31, 2017, as well as any automatic increase in the number of shares of common stock reserved for future issuance under the 2016 Plan.

S-18



© AveXis, Inc. All Rights Reserved.